Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLegal & General Regulatory News (LGEN)

Share Price Information for Legal & General (LGEN)

Share Price is delayed by 15 minutes
Get Live Data
283.20    -2.00 (-0.70%)
Bid:
283.50
Ask:
283.70
Spread: 0.20 (0.071%)
Market Cap: £15.52b
LGEN Live PriceLast checked at - London Stock Exchange

Intraday Legal & General Share Chart

Publication of Final Terms

28 Mar 2025 11:00

RNS Number : 7155C
Legal & General Group Plc
28 March 2025
 

Legal & General Group PlcPublication of Final Terms 28 March 2025

 

Publication of Final Terms pursuant to the issue of £600,000,000 Fixed Rate Tier 2 Notes due 2055 by Legal & General Group Plc

The Final Terms dated 28 March relating to the issue by Legal & General Group Plc of £600,000,000 Fixed Rate Tier 2 Notes due 2055 (the "Notes") have been filed with the Financial Conduct Authority (the "FCA") and are available for viewing.

The Notes will be issued under the £5,000,000,000 Euro Note Programme of Legal & General Group Plc and Legal & General Finance PLC.

The Final Terms should be read in conjunction with the Base prospectus dated 21 March 2025 (the "Prospectus"), which constitutes a base prospectus for the purposes of Regulation (EU) 2017/1129, as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018.

To view the Final Terms, please paste the following URL into the address bar of your browser: http://www.rns-pdf.londonstockexchange.com/rns/7155C_1-2025-3-28.pdf

Copies of the following documents are also available from the websites listed below:

Prospectus approved by the FCA on 21 March 2025 relating to the Programme http://www.rns-pdf.londonstockexchange.com/rns/7155C_2-2025-3-28.pdf

A copy of the Final Terms will be submitted to the National Storage Mechanism and will shortly be available for viewing online at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

For further information, please contact:

Monika RemenyiHead of Funding and DCMLegal & General Group PlcOne Coleman StreetLondonEC2R 5AATelephone: 020 3124 2064

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Prospectus and the Final Terms may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus and Final Terms) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus and the Final Terms is not addressed. Prior to relying on the information contained in the Prospectus and the Final Terms you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.

In particular, the Final Terms and the Prospectus do not constitute an offer of Notes for sale in the United States. This is not for distribution in the United States. The Notes described herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or with any securities regulatory authority of any State or other jurisdiction of the United States, and the Notes are subject to U.S. federal income tax law requirements. The Notes may not be offered, sold, or delivered in the United States or to, or for the benefit of, U.S. persons (as defined in Regulation S under the Securities Act) except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act.

Your right to access this service is conditional upon complying with the above requirement.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFTBGGDXGUDDGUI
Date   Source Headline
15th Jun 20266:15 pmRNSTransaction in Own Shares
9th Jun 20266:15 pmRNSDirector/PDMR Shareholding
8th Jun 20266:15 pmRNSDirector/PDMR Shareholding
8th Jun 20266:15 pmRNSTransaction in Own Shares
2nd Jun 20266:15 pmRNSDirector/PDMR Shareholding
2nd Jun 20266:15 pmRNSDirector/PDMR Shareholding
1st Jun 20266:15 pmRNSDirector/PDMR Shareholding
1st Jun 20266:15 pmRNSAdmission to Trading
1st Jun 20266:15 pmRNSTotal Voting Rights
1st Jun 20266:15 pmRNSTransaction in Own Shares
26th May 20266:15 pmRNSTransaction in Own Shares
26th May 20269:00 amRNSOutcome of Audit Tender
21st May 20264:15 pmRNSResult of AGM and GM
20th May 20266:15 pmRNSDirector/PDMR Shareholding
18th May 20266:15 pmRNSTransaction in Own Shares
11th May 20266:15 pmRNSTransaction in Own Shares
5th May 20266:15 pmRNSDirector/PDMR Shareholding
5th May 20266:15 pmRNSTransaction in Own Shares
5th May 202612:15 pmRNSHolding(s) in Company
1st May 20266:15 pmRNSDirector/PDMR Shareholding
1st May 20266:15 pmRNSAdmission to Trading
1st May 20266:15 pmRNSTotal Voting Rights
1st May 20266:15 pmRNSDirector/PDMR Shareholding
28th Apr 20266:15 pmRNSDirector/PDMR Shareholding
27th Apr 20266:15 pmRNSTransaction in Own Shares
21st Apr 20266:15 pmRNSDirector/PDMR Shareholding
20th Apr 20266:15 pmRNSTransaction in Own Shares
13th Apr 20266:15 pmRNSTransaction in Own Shares
10th Apr 20266:15 pmRNSDirector/PDMR Shareholding
10th Apr 20266:15 pmRNSDirector/PDMR Shareholding
10th Apr 20266:15 pmRNSDirector/PDMR Shareholding
10th Apr 20266:15 pmRNSDirector/PDMR Shareholding
10th Apr 20266:15 pmRNSDirector/PDMR Shareholding
9th Apr 202610:00 amRNSNotice of 2026 AGM and GM
8th Apr 20266:15 pmRNSDirector/PDMR Shareholding
8th Apr 20266:15 pmRNSDirector/PDMR Shareholding
7th Apr 20266:15 pmRNSTransaction in Own Shares
1st Apr 20266:15 pmRNSAdmission to Trading
1st Apr 20266:15 pmRNSDirector/PDMR Shareholding
1st Apr 20266:15 pmRNSDirector/PDMR Shareholding
1st Apr 20266:15 pmRNSDirector/PDMR Shareholding
1st Apr 20266:15 pmRNSTotal Voting Rights
1st Apr 20261:30 pmRNSPublication of a Prospectus
30th Mar 20266:15 pmRNSTransaction in Own Shares
26th Mar 20266:15 pmRNSDirector/PDMR Shareholding
24th Mar 20266:15 pmRNSDirector/PDMR Shareholding
20th Mar 20266:15 pmRNSDirector/PDMR Shareholding
18th Mar 20266:15 pmRNSDirector/PDMR Shareholding
18th Mar 202612:00 pmRNSAnnual Financial Report
16th Mar 20266:15 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.